Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Capital Expenditures: 2009-2023

Historic Capital Expenditures for Fortress Biotech (FBIO) over the last 13 years, with Dec 2023 value amounting to $63,000.

  • Fortress Biotech's Capital Expenditures fell 139600.00% to -$1.4 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29,000, marking a year-over-year decrease of 76.98%. This contributed to the annual value of $63,000 for FY2023, which is 97.68% down from last year.
  • Per Fortress Biotech's latest filing, its Capital Expenditures stood at $63,000 for FY2023, which was down 97.68% from $2.7 million recorded in FY2022.
  • Over the past 5 years, Fortress Biotech's Capital Expenditures peaked at $4.6 million during FY2021, and registered a low of $63,000 during FY2023.
  • Moreover, its 3-year median value for Capital Expenditures was $2.7 million (2022), whereas its average is $2.4 million.
  • Per our database at Business Quant, Fortress Biotech's Capital Expenditures skyrocketed by 137.07% in 2021 and then tumbled by 97.68% in 2023.
  • Fortress Biotech's Capital Expenditures (Yearly) stood at $2.3 million in 2019, then dropped by 17.87% to $1.9 million in 2020, then skyrocketed by 137.07% to $4.6 million in 2021, then tumbled by 40.54% to $2.7 million in 2022, then crashed by 97.68% to $63,000 in 2023.